The Joint Corp. (JYNT)
USD 10.56
(6.99%)
USD 10.56
(6.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -9.75 Million USD | -928.39% |
| 2022 | 1.17 Million USD | -84.44% |
| 2021 | 7.56 Million USD | -42.55% |
| 2020 | 13.16 Million USD | 296.16% |
| 2019 | 3.32 Million USD | 1213.29% |
| 2018 | 253.08 Thousand USD | 107.73% |
| 2017 | -3.27 Million USD | 78.42% |
| 2016 | -15.17 Million USD | -72.48% |
| 2015 | -8.79 Million USD | -190.22% |
| 2014 | -3.03 Million USD | -2047.65% |
| 2013 | 155.63 Thousand USD | 121.14% |
| 2012 | -736.29 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.59 Million USD | -479.78% |
| 2024 Q1 | 946.97 Thousand USD | 108.58% |
| 2023 FY | -9.75 Million USD | -928.39% |
| 2023 Q3 | -716.27 Thousand USD | -276.23% |
| 2023 Q4 | -11.04 Million USD | -1441.53% |
| 2023 Q1 | 2.32 Million USD | 325.11% |
| 2023 Q2 | -190.38 Thousand USD | -108.18% |
| 2022 Q4 | 547.19 Thousand USD | -25.15% |
| 2022 Q1 | -205.79 Thousand USD | -192.06% |
| 2022 Q2 | 344.74 Thousand USD | 267.52% |
| 2022 Q3 | 731.09 Thousand USD | 112.07% |
| 2022 FY | 1.17 Million USD | -84.44% |
| 2021 Q1 | 2.31 Million USD | -78.23% |
| 2021 FY | 7.56 Million USD | -42.55% |
| 2021 Q2 | 2.68 Million USD | 15.97% |
| 2021 Q3 | 1.93 Million USD | -27.83% |
| 2021 Q4 | 223.55 Thousand USD | -88.46% |
| 2020 Q1 | 814.94 Thousand USD | -36.92% |
| 2020 Q2 | 115.58 Thousand USD | -85.82% |
| 2020 Q3 | 1.6 Million USD | 1287.69% |
| 2020 FY | 13.16 Million USD | 296.16% |
| 2020 Q4 | 10.63 Million USD | 562.91% |
| 2019 Q4 | 1.29 Million USD | 109.38% |
| 2019 Q2 | 462.26 Thousand USD | -51.48% |
| 2019 Q1 | 952.64 Thousand USD | 14.15% |
| 2019 FY | 3.32 Million USD | 1213.29% |
| 2019 Q3 | 616.98 Thousand USD | 33.47% |
| 2018 Q3 | -151.8 Thousand USD | -254.86% |
| 2018 FY | 253.08 Thousand USD | 107.73% |
| 2018 Q4 | 834.56 Thousand USD | 649.77% |
| 2018 Q2 | -42.77 Thousand USD | 88.94% |
| 2018 Q1 | -386.9 Thousand USD | -81.48% |
| 2017 Q1 | -1.64 Million USD | 71.41% |
| 2017 FY | -3.27 Million USD | 78.42% |
| 2017 Q4 | -213.19 Thousand USD | 47.2% |
| 2017 Q3 | -403.8 Thousand USD | 60.06% |
| 2017 Q2 | -1.01 Million USD | 38.61% |
| 2016 Q1 | -3.52 Million USD | -4.26% |
| 2016 FY | -15.17 Million USD | -72.48% |
| 2016 Q4 | -5.76 Million USD | -119.29% |
| 2016 Q3 | -2.62 Million USD | 19.45% |
| 2016 Q2 | -3.26 Million USD | 7.48% |
| 2015 Q1 | -1.9 Million USD | 25.84% |
| 2015 Q3 | -1.65 Million USD | 10.73% |
| 2015 Q2 | -1.85 Million USD | 2.51% |
| 2015 Q4 | -3.38 Million USD | -104.08% |
| 2015 FY | -8.79 Million USD | -190.22% |
| 2014 FY | -3.03 Million USD | -2047.65% |
| 2014 Q1 | -127.89 Thousand USD | -48344.7% |
| 2014 Q4 | -2.56 Million USD | -1168.55% |
| 2014 Q2 | -133.74 Thousand USD | -4.58% |
| 2014 Q3 | -202.37 Thousand USD | -51.31% |
| 2013 Q3 | 42.54 Thousand USD | 0.0% |
| 2013 Q4 | -264.00 USD | -100.62% |
| 2013 FY | 155.63 Thousand USD | 121.14% |
| 2012 FY | -736.29 Thousand USD | 0.0% |
| 2001 Q3 | 1.93 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 54.991% |
| Addus HomeCare Corporation | 62.51 Million USD | 115.6% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -117.732% |
| Amedisys, Inc. | -9.74 Million USD | -0.053% |
| American Oncology Network, Inc. | -5.54 Million USD | -75.969% |
| Astrana Health, Inc. | 60.71 Million USD | 116.062% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 92.751% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 394.095% |
| Cryo-Cell International, Inc. | -9.52 Million USD | -2.421% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 113.427% |
| COMPASS Pathways plc | -118.46 Million USD | 91.768% |
| DocGo Inc. | 6.85 Million USD | 242.192% |
| The Ensign Group, Inc. | 209.39 Million USD | 104.657% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 125.406% |
| InnovAge Holding Corp. | -21.33 Million USD | 54.297% |
| Assure Holdings Corp. | -26.07 Million USD | 62.604% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 94.764% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 37.497% |
| ModivCare Inc. | -204.46 Million USD | 95.23% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 7590.569% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | 26.201% |
| Option Care Health, Inc. | 267.09 Million USD | 103.651% |
| P3 Health Partners Inc. | -57.77 Million USD | 83.12% |
| P3 Health Partners Inc. | -57.77 Million USD | 83.12% |
| The Pennant Group, Inc. | 13.37 Million USD | 172.892% |
| Surgery Partners, Inc. | -11.9 Million USD | 18.049% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -231.894% |
| Talkspace, Inc. | -19.18 Million USD | 49.16% |
| Talkspace, Inc. | -19.18 Million USD | 49.16% |
| The Oncology Institute, Inc. | -83.06 Million USD | 88.26% |
| The Oncology Institute, Inc. | -83.06 Million USD | 88.26% |